Literature DB >> 18525386

Contemporary trends in cardiac rehabilitation in Germany: patient characteristics, drug treatment, and risk-factor management from 2000 to 2005.

Kurt Bestehorn1, Karl Wegscheider, Heinz Völler.   

Abstract

BACKGROUND: Cardiac rehabilitation (CR) has a pivotal role in the management of patients with coronary heart disease. We aimed to describe temporal trends and centre variances of patient characteristics, drug prescriptions, and risk-factor management of in-patients in inpatient CR in Germany.
METHODS: Data on 117 983 inpatients in CR, obtained from two large-scale registries (Transparency Registry to Objectify Guideline-Oriented Risk-Factor Management and Registry of Guidelines) were pooled resulting in a database of six yearly cross-sectional samples, repeated over centres. For each response variable, a three-level mixed model (patients within years within centres) shifted to the data. Statistical tests were performed on average time trends over groups, average group levels over years, and on parallelism of trends within groups.
RESULTS: Compared with patients in CR in 2000, patients in CR in 2005 were significantly older and had a higher BMI. They, however, also showed improved control over blood pressure, lipids, and glucose at the beginning of rehabilitation; their use of angiotensin-converting enzyme inhibitors and beta-blockers had increased; whereas their use of statin and acetylsalicylic acid remained relatively stable. At discharge, no changes were noted for blood pressure and glucose--at a high target-level attainment of more than 80%. Lipid values, however, tended to improve over time, with an increase in target-level attainment from 45 to 55%. Large centre effects were noted for age, total cholesterol at entry, and exercise capacity at entry and discharge. In general, sex differences were limited. DISCUSSION: Compared with previous findings, general management of risk factors before initiation of CR, as well as control over lipid, hypertension, and glucose levels at discharge from CR, have improved over time: this is probably due to more intensive drug treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18525386     DOI: 10.1097/HJR.0b013e3282f40e14

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  4 in total

1.  Prevalence and overlap of different lipid abnormalities in statin-treated patients at high cardiovascular risk in clinical practice in Germany.

Authors:  Anselm K Gitt; Claus Jünger; Wenefrieda Smolka; Kurt Bestehorn
Journal:  Clin Res Cardiol       Date:  2010-06-03       Impact factor: 5.460

2.  Current state of cardiac rehabilitation in Germany: patient characteristics, risk factor management and control status, by education level.

Authors:  Kurt Bestehorn; Christina Jannowitz; Martin Horack; Barbara Karmann; Martin Halle; Heinz Völler
Journal:  Vasc Health Risk Manag       Date:  2011-10-31

3.  Cardiovascular risk factor management of myocardial infarction patients with and without diabetes in the Netherlands between 2002 and 2006: a cross-sectional analysis of baseline data.

Authors:  Sabita S Soedamah-Muthu; Johanna M Geleijnse; Erik J Giltay; Daan Kromhout
Journal:  BMJ Open       Date:  2012-10-31       Impact factor: 2.692

4.  Treatment patterns and risk factor control in patients with and without metabolic syndrome in cardiac rehabilitation.

Authors:  Anselm Gitt; Christina Jannowitz; Marthin Karoff; Barbara Karmann; Martin Horack; Heinz Völler
Journal:  Vasc Health Risk Manag       Date:  2012-04-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.